Norman Marcus Pain Institute is a clinical research site located in New York, New York, United States 10016.
Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.
Norman Marcus Pain Institute has participated in 1 clinical trials.
Therapeutic areas: Mast Cell Activation Syndrome, Mast Cell Activation Disorder Idiopathic.
Sponsors: Quantum Biopharma.
Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Norman Marcus Pain Institute has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Norman Marcus Pain Institute has 1 clinical trials on record. Their work covers Mast Cell Activation Syndrome, Mast Cell Activation Disorder Idiopathic.
Norman Marcus Pain Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.